JP6334285B2 - Aggregation state detection method, aggregation state control method, aggregation state detection device, and aggregation state control device - Google Patents

Aggregation state detection method, aggregation state control method, aggregation state detection device, and aggregation state control device Download PDF

Info

Publication number
JP6334285B2
JP6334285B2 JP2014127192A JP2014127192A JP6334285B2 JP 6334285 B2 JP6334285 B2 JP 6334285B2 JP 2014127192 A JP2014127192 A JP 2014127192A JP 2014127192 A JP2014127192 A JP 2014127192A JP 6334285 B2 JP6334285 B2 JP 6334285B2
Authority
JP
Japan
Prior art keywords
solid
gel
aggregate
image
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014127192A
Other languages
Japanese (ja)
Other versions
JP2016006395A (en
Inventor
徳介 早見
徳介 早見
大介 堀川
大介 堀川
良一 有村
良一 有村
聡美 海老原
聡美 海老原
美意 早見
美意 早見
卓 毛受
卓 毛受
相馬 孝浩
孝浩 相馬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toshiba Corp
Toshiba Infrastructure Systems and Solutions Corp
Original Assignee
Toshiba Corp
Toshiba Infrastructure Systems and Solutions Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toshiba Corp, Toshiba Infrastructure Systems and Solutions Corp filed Critical Toshiba Corp
Priority to JP2014127192A priority Critical patent/JP6334285B2/en
Publication of JP2016006395A publication Critical patent/JP2016006395A/en
Application granted granted Critical
Publication of JP6334285B2 publication Critical patent/JP6334285B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明の実施形態は、凝集状態検出方法、凝集状態制御方法、凝集状態検出装置及び凝集状態制御装置に関する。   Embodiments described herein relate generally to an aggregation state detection method, an aggregation state control method, an aggregation state detection device, and an aggregation state control device.

上下水道、排水処理、用水供給などの分野においては、水を浄化するために、様々な方法が考案され、実施されている。水の浄化は、水中の固形物や溶解物のうち、不要な物や後段プロセスに排出することができないものなどを除去するものである。一般的な方法としては、水槽を設置して被処理水を滞留させ、比重差と重力とにより固形物を沈降分離したり、前記沈降分離に加えて、凝結剤や凝集剤といった薬品を添加し、固形物を粗粒化させて沈降分離させる凝集沈殿法を用いたりする。他にも、多孔質のセラミクスや樹脂を用いてろ過する膜分離や、微生物に有機物などを捕食させる活性汚泥法などが挙げられる。   In the fields of water and sewage, wastewater treatment, water supply, etc., various methods have been devised and implemented for purifying water. Water purification is to remove unnecessary solids and dissolved substances in water and those that cannot be discharged to a subsequent process. As a general method, a water tank is installed to retain the water to be treated, and solids are settled and separated by the difference in specific gravity and gravity. In addition to the sedimentation, chemicals such as a coagulant and a flocculant are added. For example, a coagulation sedimentation method in which a solid is coarsened and separated by sedimentation is used. Other examples include membrane separation that filters using porous ceramics and resins, and an activated sludge method that allows microorganisms to eat organic substances.

中でも凝集沈殿法は、薬品注入、撹拌、沈殿槽の比較的単純な構成で、良好な処理水質を得やすいことから、広く普及している。上水処理の凝集沈殿法においては、被処理水に、PAC(ポリ塩化アルミニウム)や、硫酸ばん土などの凝結剤を注入し、混和池で撹拌混合し、フロキュレータで凝集物の粒子サイズの成長を促進し、沈澱池で凝集物を沈降分離するのが一般的である。産業排水処理などに於いても基本的な構成は同様であるが、凝結剤の他に高分子凝集剤を用いるなどして、凝集物の沈降速度を向上させ、高速分離する手法が用いられることもある。   Among these, the coagulation precipitation method is widely used because it has a relatively simple configuration of chemical injection, stirring, and precipitation tank, and it is easy to obtain good treated water quality. In the coagulation-precipitation method for water treatment, a coagulant such as PAC (polyaluminum chloride) or sulfated clay is injected into the water to be treated, stirred and mixed in a mixing basin, and the particle size of the aggregate is determined by a flocculator. It is common to promote growth and to separate the agglomerates in the sedimentation basin. The basic configuration is the same for industrial wastewater treatment, etc., but a technique that uses a polymer flocculant in addition to the coagulant to improve the sedimentation rate of the aggregate and to perform high-speed separation is used. There is also.

凝集沈殿法において、水処理の目的である処理水の清澄化の度合いは、除去対象の固形物濃度や、固形物の粒子径、表面の荷電状態、水の導電率やpH、水温、凝集剤などの薬剤の種類や数、注入率、撹拌強度、撹拌時間、沈殿槽の許容水面積負荷など、様々な要素により左右される。さらにこれらの濃度のうち、被処理水の水質や被処理水中の固形物に関わるものは、時間経過に従って、変動がある為、それに応じて、pHや薬剤の注入率などを調整して適正に水処理ができるように制御する必要がある。   In the coagulation sedimentation method, the degree of clarification of treated water, which is the purpose of water treatment, is the concentration of solids to be removed, particle size of solids, surface charge state, water conductivity and pH, water temperature, flocculant It depends on various factors such as the type and number of drugs, injection rate, stirring intensity, stirring time, allowable water area load of the precipitation tank, and the like. Furthermore, among these concentrations, those related to the quality of the water to be treated and the solids in the water to be treated vary over time, so adjust the pH and the injection rate of the drug accordingly and adjust appropriately. It is necessary to control water treatment.

このような問題に鑑みて、従来から、特に上水分野において、濁度やアルカリ度を指標とした、凝集剤の注入率の定式化が行われてきた。水処理施設の現場では、こういった指標とビーカー規模での実際の凝集試験(ジャーテスト)の結果とを組み合わせて、薬剤注入率を決定するのが一般的である。   In view of such a problem, conventionally, in the field of water supply, for example, the formulation of the flocculant injection rate has been performed using turbidity and alkalinity as indexes. In the field of water treatment facilities, it is common to determine the drug injection rate by combining these indicators with the results of an actual agglutination test (jar test) at the beaker scale.

しかし、それだけではあまり精度良く凝集状態をコントロールすることができず、また、必ずしも専門知識が豊富でない水処理施設の運転員の心情として、凝集状態が悪化した際には薬剤を多く注入したくなるなどの作用もあり、常に薬剤量が適正であるとは言えない状況が発生する。   However, it is not possible to control the aggregation state with high accuracy by itself, and it is not necessarily abundant in specialist knowledge that the operator wants to inject a lot of medicine when the aggregation state deteriorates. For example, there are situations where the amount of drug is not always appropriate.

そこで近年では、散乱光による凝集物の形成状態の測定など、より高度な凝集状態の検出方法が考案されてきた(特許文献1)。散乱光法は濁度測定などによく用いられる、粒子濃度測定の手法であり、水にレーザー光を当てて、粒子により散乱された光の強度を測定するものである。薬剤注入後、凝集物形成の為に撹拌する水槽の中で、凝集物形成過程の散乱光を測定することで、水中の粒子濃度から凝集物の形成状態を知ることができるものである。   Therefore, in recent years, a more advanced method for detecting an aggregate state has been devised, such as measurement of the aggregate formation state using scattered light (Patent Document 1). The scattered light method is a particle concentration measurement technique often used for turbidity measurement, and measures the intensity of light scattered by particles by applying laser light to water. By measuring the scattered light in the agglomerate formation process in a water tank that is stirred for agglomerate formation after the injection of the drug, the formation state of the agglomerate can be known from the concentration of particles in water.

しかしながら、こういった手法においては、ある範囲(検出器が光を回収できる範囲)の測定箇所の集約値として一点の数値が出力されるため、出力値が振れやすく、安定的に測定することが難しいという課題がある。さらに、凝集物の影を測定しているのと同義であり、凝集物の内容が良いかどうかについては、全く知ることができないといった課題がある。   However, in such a method, since a single numerical value is output as an aggregated value of measurement points within a certain range (a range in which the detector can collect light), the output value is likely to fluctuate and can be measured stably. There is a problem that it is difficult. Furthermore, it is synonymous with measuring the shadow of the aggregate, and there is a problem that it cannot be known at all whether or not the content of the aggregate is good.

特開2005−241338号JP 2005-241338 A

本発明は、凝集物の凝集状態をより精度よく検出し、制御する方法を提供することを目的とする。   An object of this invention is to provide the method of detecting and controlling the aggregate state of an aggregate more accurately.

実施形態の凝集状態検出方法は、薬剤を用いて被処理水中の固形物を凝集させ、前記固形物及びこの固形物を囲むようにして形成されたゲル状物を含む凝集物を得るステップと、前記凝集物を撮像手段によって前記凝集物の明視野像及び位相差像を得るステップとを具える。また、前記明視野像及び前記位相差像に対して画像処理を行い、前記明視野像及び前記位相差像間の差分画像を得るステップと、前記差分画像に基づいて、前記凝集物中の前記固形物と前記ゲル状物とを識別するステップとを具える。   The aggregation state detection method of the embodiment includes a step of aggregating solids in water to be treated using a chemical agent to obtain an aggregate including the solids and a gel-like material formed so as to surround the solids, and the aggregation Obtaining a bright field image and a phase difference image of the aggregate by imaging means. Further, image processing is performed on the bright field image and the phase difference image to obtain a difference image between the bright field image and the phase difference image, and based on the difference image, the aggregate in the aggregate Identifying a solid and the gel.

実施形態における凝集沈殿装置の概略構成を示す図である。It is a figure which shows schematic structure of the coagulation sedimentation apparatus in embodiment. 実施形態における凝集状態検出装置の概略構成を示す図である。It is a figure which shows schematic structure of the aggregation state detection apparatus in embodiment. 凝集物の明視野像及び位相差像を示す写真である。It is a photograph which shows the bright field image and phase contrast image of an aggregate. 明視野像及び位相差像の減算処理(差分処理)を行って得た画像を示す写真である。It is a photograph which shows the image obtained by performing the subtraction process (difference process) of a bright field image and a phase difference image. 薬剤の量を3段階に変化させた場合に得た凝集物の、明視野像及び位相差像の減算処理(差分処理)に基づく画像を示す写真である。It is a photograph which shows the image based on the subtraction process (difference process) of the bright-field image and phase difference image of the aggregate obtained when changing the quantity of a chemical | medical agent in three steps. 凝集物のゲル状物に対する固形物の面積比を示すグラフである。It is a graph which shows the area ratio of the solid substance with respect to the gel-like thing of an aggregate.

(凝集プロセス)
図1は、実施形態における凝集沈殿装置の概略構成を示す図である。
図1に示すように、本実施形態の凝集沈殿装置10は、被処理水W0を貯留するための貯留槽11と、この貯留槽11に隣接して配設された凝集物を形成するための第1の凝集槽12と、この第1の凝集槽12に隣接して配設された凝集物を粗粒化するための第2の凝集槽13と、この第2の凝集槽13に隣接して配設され粗粒化した凝集物を沈殿させるための沈殿槽14とを有する。
(Agglomeration process)
Drawing 1 is a figure showing the schematic structure of the coagulation sedimentation device in an embodiment.
As shown in FIG. 1, the coagulation sedimentation apparatus 10 of the present embodiment forms a storage tank 11 for storing the water to be treated W0 and an aggregate disposed adjacent to the storage tank 11. A first agglomeration tank 12, a second agglomeration tank 13 for coarsening the agglomerates disposed adjacent to the first agglomeration tank 12, and the second agglomeration tank 13. And a sedimentation tank 14 for precipitating the coarsely agglomerated aggregates.

また、第1の凝集槽12の上流側にはポンプ18を介して薬剤(凝集剤)Pが入った薬剤貯留槽15が配設されている。さらに、第1の凝集槽12及び第2の凝集槽13中には、それぞれ第1の攪拌機16及び第2の攪拌機17が配設されている。   In addition, a medicine storage tank 15 containing a medicine (flocculating agent) P is disposed via a pump 18 on the upstream side of the first aggregation tank 12. Further, a first stirrer 16 and a second stirrer 17 are disposed in the first aggregating tank 12 and the second aggregating tank 13, respectively.

第1の攪拌機16は、一端側に攪拌翼16Aが配設され、他端側にモータ16Bが配設されている。第2の撹拌機17は、第1の攪拌機16同様に、一端側に攪拌翼17Aが配設され、他端側にモータ17Bが配設されている。   The first stirrer 16 is provided with a stirring blade 16A on one end side and a motor 16B on the other end side. As with the first stirrer 16, the second stirrer 17 is provided with a stirring blade 17A on one end side and a motor 17B on the other end side.

次に、図1に示す凝集沈殿装置10を用いた凝集沈殿方法について説明する。
最初に、被処理水W0を貯留槽11内に貯留し、その後、被処理水W0はヘッド差や図示しないポンプを用いて第1の凝集槽12内に送水する。第1の凝集槽12では、薬剤貯留槽15より所定の薬剤(凝結剤や凝集剤等)Pを供給し、第1の攪拌機16を駆動することによって被処理水W0と均一に混合する。その結果、被処理水W0中の懸濁粒子や、一部溶解成分などの固形物が、薬剤による荷電中和作用やファンデルワールス力によって寄り集まり、凝集物S1を形成していく。なお、第1の攪拌機16による撹拌は、薬剤を比較的早く分散させると同時に、懸濁粒子などの固形物や凝集物と薬剤との衝突確率を向上させる作用を有する。
Next, a coagulation sedimentation method using the coagulation sedimentation apparatus 10 shown in FIG. 1 will be described.
First, the water to be treated W0 is stored in the storage tank 11, and then the water to be treated W0 is fed into the first aggregating tank 12 using a head difference or a pump (not shown). In the first coagulation tank 12, a predetermined chemical (coagulant, coagulant, etc.) P is supplied from the chemical reservoir 15, and the first agitator 16 is driven to uniformly mix with the water to be treated W 0. As a result, the suspended particles in the water to be treated W0 and solids such as partially dissolved components gather together due to the charge neutralization action and van der Waals force by the chemicals to form the aggregate S1. In addition, the stirring by the first stirrer 16 has an effect of improving the collision probability between the drug and the solid matter or aggregates such as suspended particles while dispersing the drug relatively quickly.

また、第1の凝集槽12内には、凝集物の形成速度を促進させるために、塩酸、硫酸といった酸類や、消石灰、苛性ソーダといったアルカリ類を添加して適宜pH調整を行うこともできる。   Further, in order to accelerate the formation rate of aggregates, the pH can be adjusted appropriately by adding acids such as hydrochloric acid and sulfuric acid, and alkalis such as slaked lime and caustic soda.

次いで、第1の凝集槽12内の、凝集物S1を含む被処理水W0は、ヘッド差や図示しないポンプを用いて第2の凝集槽13内に送水する。第2の凝集槽13内では、第2の攪拌機17を駆動させることにより、第1の凝集槽12内で得た凝集物S1同士を衝突させて当該凝集物S1を成長させ、粗粒化した凝集物S2を得る。   Subsequently, the to-be-processed water W0 containing the aggregate S1 in the 1st aggregation tank 12 is sent into the 2nd aggregation tank 13 using a head difference or a pump which is not illustrated. In the second agglomeration tank 13, by driving the second agitator 17, the agglomerates S1 obtained in the first agglomeration tank 12 collide with each other to grow and coarsen the agglomerates S1. Aggregate S2 is obtained.

次いで、第2の凝集槽12内の、凝集物S2を含む被処理水W0は、ヘッド差や図示しないポンプを用いて沈殿槽14に送水する。沈殿槽14内では、粗粒化した凝集物S2を重力沈降によって分離し、凝集物S2が除去された被処理水W0は処理水W1として沈殿槽14より外部に排出される。   Subsequently, the to-be-processed water W0 containing the aggregate S2 in the 2nd aggregation tank 12 is sent to the sedimentation tank 14 using a head difference or a pump which is not illustrated. In the sedimentation tank 14, the coarsely aggregated aggregate S2 is separated by gravity sedimentation, and the water to be treated W0 from which the aggregate S2 has been removed is discharged from the sedimentation tank 14 to the outside as the treated water W1.

(凝集状態検出装置(凝集状態制御装置))
図2は、実施形態における凝集状態検出装置の概略構成を示す図である。
図2に示す凝集状態検出装置20は、被処理水W0中の懸濁粒子などの固形物を第1の凝集槽12中で薬剤を用いて凝集させて得た凝集物S1を第1の凝集槽12から取出し、当該凝集物S1の、以下に説明する明視野像及び位相差像を得るための撮像手段としてのカメラ22と、明視野像及び位相差像に対して画像処理を行い、明視野像及び位相差像間の差分画像を得、差分画像に基づいて、凝集物の形態や、凝集物中の固形物と、後に説明するゲル状物とを識別するための演算手段としてのコンピュータ23とを有している。
(Aggregation state detection device (aggregation state control device))
FIG. 2 is a diagram illustrating a schematic configuration of the aggregation state detection device according to the embodiment.
The agglomeration state detection apparatus 20 shown in FIG. 2 is configured to agglomerate S1 obtained by aggregating solids such as suspended particles in the water to be treated W0 using a chemical in the first agglomeration tank 12. An image processing is performed on the bright field image and the phase difference image, and the camera 22 as an imaging means for obtaining the bright field image and the phase difference image, which will be described below, of the aggregate S1, which is taken out from the tank 12. A computer as a computing means for obtaining a difference image between a field image and a phase difference image, and discriminating the form of the aggregate, the solid matter in the aggregate and the gel-like substance described later based on the difference image 23.

なお、本実施形態の凝集状態検出装置20は、凝集物S1をカメラ22のレンズ下に支持及び固定するための支持板21を有している。支持板21へはスポイトなどの吸引手段で凝集物が液中に懸濁されたまま取り出し固定するのが望ましい。凝集物S1は一般に崩れやすく固定することが難しい為、ポンプなどを用いて水中に懸濁されたまま凝集槽12より取り出し、フローセルを用いて通水しながらレンズ下を凝集物を通過させ、撮影してもよい。   Note that the aggregation state detection device 20 of the present embodiment includes a support plate 21 for supporting and fixing the aggregate S1 under the lens of the camera 22. It is desirable that the support plate 21 be taken out and fixed while the aggregates are suspended in the liquid by a suction means such as a dropper. Since the aggregate S1 is generally easy to collapse and difficult to fix, it is taken out from the aggregation tank 12 while being suspended in water using a pump or the like, and the aggregate is passed under the lens while passing water using a flow cell. May be.

また、本実施形態では、凝集状態を検出する凝集物として第1の凝集槽12中で得た凝集物S1を選択しているが、第2の凝集槽13中で得た粗粒化した凝集物S2であってもよいし、沈殿槽14で沈殿した凝集物S2であってもよい。   Moreover, in this embodiment, although the aggregate S1 obtained in the 1st aggregation tank 12 is selected as an aggregate which detects an aggregation state, the coarse-grained aggregation obtained in the 2nd aggregation tank 13 is selected. The substance S2 may be sufficient, and the aggregate S2 settled in the sedimentation tank 14 may be sufficient.

さらに、コンピュータ23に以下に説明するような薬剤Pの供給量の制御機能を付加することにより、コンピュータ23は演算制御手段として機能するようになる。   Furthermore, by adding a function for controlling the supply amount of the medicine P as described below to the computer 23, the computer 23 functions as an arithmetic control means.

(凝集状態検出方法(凝集状態制御方法))
次に、図2に示す凝集状態検出装置(凝集状態制御装置)20を用いた凝集状態検出方法(凝集状態制御方法)について説明する。
(Aggregation state detection method (aggregation state control method))
Next, an aggregation state detection method (aggregation state control method) using the aggregation state detection device (aggregation state control device) 20 shown in FIG. 2 will be described.

<凝集物の形態>
最初に、凝集物の形態について説明する。
処理水W1の固形物濃度については、水処理をする目的でもあり、予め決められた水準を守らねばならない。凝集状態が悪化することにより、例えば第2の凝集槽13における粗粒化が十分でなければ、沈殿槽14の設計に見合った十分な沈降速度を得られず、処理水W1の固形物濃度は容易に悪化する。原因としては、被処理水W0中の固形物濃度が第1の凝集槽12において変動したにも関わらず、薬剤注入条件を適正な範囲に合わせることができない場合などによる。
<Form of aggregate>
First, the form of the aggregate will be described.
About the solid substance density | concentration of the treated water W1, it is also the objective of water-treating and it must observe a predetermined level. If the agglomeration state is deteriorated, for example, if the coarsening in the second agglomeration tank 13 is not sufficient, a sufficient sedimentation speed corresponding to the design of the precipitation tank 14 cannot be obtained, and the solids concentration of the treated water W1 is It gets worse easily. The cause is that the concentration of the solids in the water to be treated W0 has fluctuated in the first flocculation tank 12 but the chemical injection conditions cannot be adjusted to an appropriate range.

固形物は、薬剤(凝結剤や凝集剤等)の濃度がある濃度に達するまでは、凝集は起こらないとされており、当該濃度は臨界凝集濃度と呼ばれている。それ以上の濃度域になると、凝集が始まり凝集物が形成され始めるが、濃度に応じて状態が異なる。水処理の目的は、懸濁粒子などの固形物を凝集させて分離し、水を清澄にすることであるので、薬剤の濃度を増加させて清澄な処理水が得られた濃度が、適正な薬剤注入量であると言える。これ未満の濃度においては、相対的に懸濁粒子量に対して薬剤量が不足しており、細かな凝集不足の粒子、すなわち固形物が水中に漂い、処理水W1中の固形物濃度が高い状態となる。   It is said that the solid does not aggregate until the concentration of the drug (coagulant, flocculant, etc.) reaches a certain concentration, and this concentration is called the critical aggregation concentration. When the concentration is higher than that, aggregation starts and aggregates start to form, but the state varies depending on the concentration. The purpose of water treatment is to agglomerate and separate solids such as suspended particles and clarify the water. Therefore, the concentration of the purified treatment water obtained by increasing the concentration of the drug is appropriate. It can be said that it is a drug injection amount. If the concentration is lower than this, the amount of drug is relatively insufficient with respect to the amount of suspended particles, finely aggregated particles, that is, solids drift in the water, and the solids concentration in the treated water W1 is high. It becomes a state.

また、薬剤の注入濃度を増加させた際には、徐々に薬剤が過剰となっていくが、薬剤同士が凝集する作用を持つため、ある程度の濃度範囲までは、清澄な処理水を得ることができる。さらに濃度が高くなると、薬剤同士が凝集しきれなくなり、しかも相対的に多くの薬剤が、相対的に少ない固形物を取りあう形となるので、凝集物S1が粗粒化されなくなり、凝集物S1の沈降性が悪化し、結果として処理水W1の固形物濃度が上昇してしまう結果となる。   In addition, when the injection concentration of the drug is increased, the drug gradually becomes excessive, but since the drugs have an action of aggregating, it is possible to obtain clear treated water up to a certain concentration range. it can. When the concentration is further increased, the drugs cannot be aggregated together, and a relatively large number of drugs are in a form of relatively solid solids, so that the aggregate S1 is not coarsened and the aggregate S1. As a result, the solids concentration of the treated water W1 increases.

さらに、被処理水W0に薬剤を添加すると汚泥が増加する。すなわち、懸濁粒子などの固形物の量に加えて、薬剤量が汚泥として加算される。しかしながら、実際は、薬剤量以上に汚泥は増加する。これは、薬剤が被処理水W0中の水を取り込むためである。凝結剤や凝集剤等の薬剤は高分子でありハイドロゲルを形成する特徴がある。PACなどの無機凝結剤と、ポリアクリルアミドなどの有機高分子凝集剤との別を問わず、分子量や組成・構造に差はあっても、いずれも親水基を多く持つ高分子体であることから、凝集して固形物化した際にはハイドロゲルを形成する。このハイドロゲルは、ゲル状物として、懸濁粒子などの固形物を囲むようにして形成される。   Furthermore, sludge increases when chemicals are added to the water to be treated W0. That is, in addition to the amount of solids such as suspended particles, the amount of drug is added as sludge. However, in actuality, sludge increases more than the amount of chemicals. This is because the medicine takes in water in the water to be treated W0. Drugs such as a coagulant and a flocculant are polymers and are characterized by forming a hydrogel. Regardless of whether it is an inorganic coagulant such as PAC or an organic polymer flocculant such as polyacrylamide, it is a polymer that has many hydrophilic groups, regardless of differences in molecular weight, composition, or structure. When agglomerated and solidified, a hydrogel is formed. This hydrogel is formed as a gel-like material so as to surround solids such as suspended particles.

したがって、得られる凝集物S1は、懸濁粒子などの固形物と、当該固形物を囲むようにして形成されたゲル状物を含むようにして構成される。   Therefore, the obtained aggregate S1 is configured to include a solid such as suspended particles and a gel-like material formed so as to surround the solid.

なお、第2の凝集槽13及び沈殿槽14で得られる粗粒化した凝集物S2も、凝集物S1同士が衝突し、成長して得られるものであり、凝集物S1と同様の構成を有する。   In addition, the coarse-aggregated aggregate S2 obtained in the second aggregation tank 13 and the sedimentation tank 14 is also obtained by the collision of the aggregates S1 with each other, and has the same configuration as the aggregate S1. .

<凝集状態検出方法(凝集状態制御方法)>
凝集状態検出装置20を用いた凝集状態の検出は、図2に示すように、第1の凝集槽12より凝集物S1を採取して、支持板21上に載置して、支持及び固定する。次いで、支持板21の上方に配設したカメラ22によって凝集物S1の明視野像及び位相差像を同じ視野で撮影する。なお、カメラ22には、例えば顕微鏡用のデジタルカメラなどを用いることができる。
<Aggregation state detection method (aggregation state control method)>
As shown in FIG. 2, the detection of the aggregation state using the aggregation state detection device 20 is performed by collecting the aggregate S1 from the first aggregation tank 12, placing it on the support plate 21, and supporting and fixing it. . Next, a bright-field image and a phase-contrast image of the aggregate S <b> 1 are taken in the same field by the camera 22 disposed above the support plate 21. For example, a digital camera for a microscope can be used as the camera 22.

図3は、凝集物S1の明視野像及び位相差像を示す写真である。図3から明らかなように、図3の左側(登録された図の左側を上として)に位置する明視野像は、凝集物S1内の固形物を観察し易いが凝集物S1の輪郭をつかむにはコントラストが不足する。一方、図3の右側(登録された図の左側を上として)に位置する位相差像は、固形物の周囲に存在する透過性のゲル状物を観察するのに向いており、凝集物S1全体が浮かび上がるため、凝集物S1の輪郭をつかむことができるが、懸濁粒子などの固形物を凝集物S1から識別するには向いていない。 FIG. 3 is a photograph showing a bright field image and a phase contrast image of the aggregate S1. As is clear from FIG. 3, the bright field image located on the left side of FIG . 3 (with the left side of the registered figure as the top) makes it easy to observe the solid matter in the aggregate S1, but grasps the outline of the aggregate S1. Lacks contrast. On the other hand, the phase difference image located on the right side of FIG. 3 (with the left side of the registered figure as the top) is suitable for observing a permeable gel-like material existing around the solid matter, and the aggregate S1. Since the whole surface emerges, the outline of the aggregate S1 can be grasped, but it is not suitable for distinguishing solids such as suspended particles from the aggregate S1.

そこで、本実施形態では、コンピュータ23によって、上述した明視野像及び位相差像の減算処理(差分処理)を行う。図4は、明視野像及び位相差像の減算処理(差分処理)を行って得た画像を示す写真である。図4に示すように、上記のようにして減算処理(差分処理)して得た画像は、凝集物S1の輪郭と、懸濁粒子などの固形物及びこの固形物の周囲に存在するゲル状物とを識別するできることが分かる。   Therefore, in the present embodiment, the computer 23 performs the above-described subtraction processing (difference processing) of the bright field image and the phase difference image. FIG. 4 is a photograph showing an image obtained by performing a subtraction process (difference process) between the bright field image and the phase difference image. As shown in FIG. 4, the image obtained by the subtraction process (difference process) as described above is the outline of the aggregate S1, the solid matter such as suspended particles, and the gel-like shape present around the solid matter. It can be seen that the object can be identified.

このような知見に鑑み、固形物として上水分野で濁度標準物質として用いられてきたカオリンの粉末、及び薬剤としてPSI(ポリシリカ鉄)の凝集剤を用い、当該薬剤の量を3段階に変化させて図4に示すような明視野像及び位相差像の減算処理(差分処理)に基づく画像を得た。なお、上記粉末は、第1の凝集槽12内に100mg/lの濃度で入れた。   In view of such knowledge, using kaolin powder, which has been used as a turbidity standard in the water supply field as a solid, and PSI (polysilica iron) flocculant as a drug, the amount of the drug is changed in three stages. Thus, an image based on the subtraction process (difference process) of the bright field image and the phase difference image as shown in FIG. 4 was obtained. In addition, the said powder was put into the 1st aggregation tank 12 by the density | concentration of 100 mg / l.

図5は、薬剤の量を3段階に変化させた場合に得た凝集物S1の、明視野像及び位相差像の減算処理(差分処理)に基づく画像を示す写真である。   FIG. 5 is a photograph showing an image based on the subtraction process (difference process) between the bright field image and the phase difference image of the aggregate S1 obtained when the amount of the drug is changed in three stages.

図5の左側(登録された図の左側を上として)の写真に示すように、薬剤を10mg/lに設定した場合は、上記粉末に対して薬剤の注入量が足りなく、当該粉末のある程度は凝集物S1を形成するものの、凝集しきれない粉末が処理水W1の上澄み中に残存していた。 As shown in the photograph on the left side of FIG. 5 (with the left side of the registered figure as the top) , when the drug was set at 10 mg / l, the amount of drug injected was insufficient with respect to the powder, and a certain amount of the powder Although the agglomerate S1 was formed, a powder that could not be agglomerated remained in the supernatant of the treated water W1.

また、図5の中央(登録された図の左側を上として)の写真に示すように、薬剤を40mg/lに設定した場合は、上記粉末に対して薬剤の注入量が適量であり、凝集物S1沈降後の処理水W1は清澄であり、上澄みには粉末はほとんど残存していなかった。 In addition, as shown in the photograph in the center of FIG. 5 (with the left side of the registered figure as the top) , when the drug is set to 40 mg / l, the drug injection amount is appropriate for the powder, and the agglomeration The treated water W1 after sedimentation of the substance S1 was clear, and almost no powder remained in the supernatant.

さらに、図5の右側(登録された図の左側を上として)の写真に示すように、薬剤を100g/lに設定した場合は、上記粉末に対して薬剤の注入量が過剰となり、相対的に多くの薬剤が、相対的に少ない固形物を取りあう形となるので、凝集物S1に占める凝集剤の比率が大きくなる。凝集物S1は形成され、沈降する為、一見良好な水処理のように見えるが、実は無駄に薬剤を使ってしまっている。 Furthermore, as shown in the photograph on the right side of FIG. 5 (with the left side of the registered figure on the top) , when the drug is set to 100 g / l, the injection amount of the drug is excessive with respect to the powder, and the relative Therefore, the ratio of the flocculant in the aggregate S1 is increased. Aggregate S1 is formed and settles, so it looks like a good water treatment at first glance.

なお、図5から明らかなように、薬剤の注入量が増加するにしたがって、薬剤が被処理水W0中の水を取り込んでより多くのハイドロゲルを形成し、凝集体S1を構成する粉末の周囲を囲むようにしてより多くのゲル状物が形成されていることが分かる。   As is clear from FIG. 5, as the amount of the injected drug increases, the drug takes in the water in the water to be treated W0 to form more hydrogel, and around the powder constituting the aggregate S1. It can be seen that more gel-like materials are formed so as to surround the.

したがって、本実施形態では、図5における画像より凝集物S1の固形物の割合とゲル状物の割合とを面積比を用いて表すようにした。図6は、凝集物S1のゲル状物に対する固形物の面積比を示すグラフである。図6における各グラフは、図5における各画像に対応する。また、図6に示すグラフは、上述した操作を10回行い、図5に示すような各画像を10種類得た状態において、その平均値、最小値、及び最大値を示したものである。   Therefore, in this embodiment, the ratio of the solid substance of the aggregate S1 and the ratio of the gel-like substance are expressed using the area ratio from the image in FIG. FIG. 6 is a graph showing the area ratio of the solid to the gel of the aggregate S1. Each graph in FIG. 6 corresponds to each image in FIG. Further, the graph shown in FIG. 6 shows the average value, the minimum value, and the maximum value in the state where the above-described operation is performed 10 times and 10 types of images as shown in FIG. 5 are obtained.

図6の左側に示すグラフは、図5の左側の画像に示すように、薬剤の注入量が不足している場合の面積比であって、凝集物S1のゲル状物に対する固形物の面積比が最も高く、その平均値は0.6となっている。   The graph shown on the left side of FIG. 6 is the area ratio when the injection amount of the drug is insufficient, as shown in the image on the left side of FIG. 5, and the area ratio of the solid to the gel of the aggregate S1 Is the highest, with an average value of 0.6.

また、図6の右側に示すグラフは、図5の右側の画像に示すように、薬剤の注入量が過剰である場合の面積比であって、薬剤に起因して多量のゲル状物が形成されていることから、その平均値は0.15となっている。   Further, the graph shown on the right side of FIG. 6 is an area ratio when the injection amount of the drug is excessive as shown in the image on the right side of FIG. 5, and a large amount of gel is formed due to the drug. Therefore, the average value is 0.15.

さらに、図6の中央に示すグラフは、図5の中央の画像に示すように、薬剤の注入量が適量の場合である場合の面積比であって、その平均値は0.5となっており、上述した薬剤の注入量が不足している場合と、薬剤の注入量が過剰の場合との中間的な値を採ることが分かる。   Furthermore, the graph shown in the center of FIG. 6 is an area ratio when the injection amount of the medicine is an appropriate amount as shown in the center image of FIG. 5, and the average value is 0.5. Thus, it can be seen that an intermediate value between the above-described case where the injection amount of the drug is insufficient and the case where the injection amount of the drug is excessive is taken.

したがって、上述した結果を鑑み、例えば面積比0.4〜0.55の場合が適当な薬剤の注入量であることが分かる。このため、上述のようにして得られた結果が、例えば面積比0.4〜0.55より小さくなる場合は、薬剤注入量が不足しているので、演算制御手段としても機能するコンピュータ23より、例えば薬剤注入槽15の下流側に配設されたポンプ18に制御信号を送信して、薬剤注入槽15内に注入する薬剤の供給量を増大させる、あるいは薬剤の供給を開始するようにする。   Therefore, in view of the above-described results, it can be seen that, for example, an area ratio of 0.4 to 0.55 is an appropriate amount of medicine to be injected. For this reason, when the result obtained as described above is smaller than, for example, an area ratio of 0.4 to 0.55, since the amount of medicine injection is insufficient, the computer 23 functioning also as a calculation control means. For example, a control signal is transmitted to the pump 18 disposed on the downstream side of the medicine injection tank 15 to increase the supply amount of the medicine injected into the medicine injection tank 15 or to start the supply of the medicine. .

一方、上述のようにして得られた結果が、例えば面積比0.4〜0.55より大きくなる場合は、薬剤注入量が過剰であるので、演算制御手段としても機能するコンピュータ23より、例えば薬剤注入槽15の下流側に配設されたポンプ18に制御信号を送信して、薬剤注入槽15内に注入する薬剤の供給量を減少させる、あるいは薬剤の供給を停止するようにする。   On the other hand, if the result obtained as described above is larger than, for example, an area ratio of 0.4 to 0.55, the amount of medicine injection is excessive. A control signal is transmitted to the pump 18 disposed on the downstream side of the medicine injection tank 15 to reduce the supply amount of the medicine injected into the medicine injection tank 15 or to stop the supply of the medicine.

以上のようにすれば、第1の凝集槽12内における凝集物S1の形成を効率的かつ効果的に行うことができるように、薬剤の供給を簡易に制御することができ、被処理水W0中に含まれる固形物(粉末)を低減して、固形物を極力含まない清浄な処理水W1を得ることができる。   If it carries out as mentioned above, supply of a chemical | medical agent can be easily controlled so that formation of the aggregate S1 in the 1st aggregation tank 12 can be performed efficiently and effectively, and the to-be-processed water W0. The solid matter (powder) contained therein can be reduced, and clean treated water W1 containing as little solid matter as possible can be obtained.

なお、図6では、凝集物S1のゲル状物に対する固形物の面積比を求め、それをグラフ化しているが、凝集物S1の固形物に対するゲル状物の面積比を求め、それをグラフ化してもよい。後者の場合、面積比の具体的な値は前者の場合と異なるようになるが、図5の中央の画像に対応するグラフの面積比は、前者の場合のように、薬剤の注入量が適量の場合に相当する面積比である。   In FIG. 6, the area ratio of the solid to the gel of the aggregate S1 is obtained and graphed, but the area ratio of the gel to the solid of the aggregate S1 is obtained and graphed. May be. In the latter case, the specific value of the area ratio is different from that in the former case. However, the area ratio of the graph corresponding to the central image in FIG. It is an area ratio corresponding to the case.

また、被処理水の水質変動が大きいなどの理由により、制御の時間遅れを考慮する場合は、凝集沈殿プロセスの早い段階、すなわち、上述のように、第1の凝集槽12内における凝集物S1を採取して上述のような画像処理及び演算処理に供することが好ましい。一方、被処理水の水質変動が小さいなど、凝集物の状態をより精度良く検出する時間的余裕がある場合は、凝集沈殿プロセスの遅い段階、例えば第2の凝集槽13や沈殿槽14における粗粒化した凝集物S2を採取して上述のような画像処理及び演算処理に供することが好ましい。   In addition, when the control time delay is taken into account due to large water quality fluctuation of the water to be treated, the agglomerate S1 in the first agglomeration tank 12 at an early stage of the agglomeration precipitation process, that is, as described above. It is preferable to collect the image and use it for the image processing and calculation processing as described above. On the other hand, when there is a time allowance for detecting the state of the aggregate with higher accuracy, such as a small change in the quality of the water to be treated, a coarse stage in the second coagulation tank 13 or the precipitation tank 14 is used. It is preferable that the agglomerated aggregate S2 is collected and used for the image processing and arithmetic processing as described above.

以上、本発明のいくつかの実施形態を説明したが、これらの実施形態は例として掲示したものであり、発明の範囲を限定することは意図していない。これら新規な実施形態は、その他の様々な形態で実施されることが可能であり、発明の要旨を逸脱しない範囲で、種々の省略、置き換え、変更を行うことができる。これら実施形態やその変形は、発明の範囲や要旨に含まれるとともに、特許請求の範囲に記載された発明とその均等の範囲に含まれる。   As mentioned above, although several embodiment of this invention was described, these embodiment was posted as an example and is not intending limiting the range of invention. These novel embodiments can be implemented in various other forms, and various omissions, replacements, and changes can be made without departing from the scope of the invention. These embodiments and modifications thereof are included in the scope and gist of the invention, and are included in the invention described in the claims and the equivalents thereof.

10 凝集沈殿装置
11 貯留槽
12 第1の凝集槽
13 第2の凝集槽
14 沈殿槽
15 薬剤貯留槽
16 第1の攪拌機
17 第2の攪拌機
18 ポンプ
20 凝集状態検出装置(凝集状態制御装置)
21 支持板
22 カメラ
23 コンピュータ
DESCRIPTION OF SYMBOLS 10 Coagulation sedimentation apparatus 11 Storage tank 12 1st aggregation tank 13 2nd aggregation tank 14 Precipitation tank 15 Drug storage tank 16 1st stirrer 17 2nd stirrer 18 Pump 20 Aggregation state detection apparatus (aggregation state control apparatus)
21 support plate 22 camera 23 computer

Claims (8)

薬剤を用いて被処理水中の固形物を凝集させ、前記固形物及びこの固形物を囲むようにして形成されたゲル状物を含む凝集物を得るステップと、
前記凝集物を撮像手段によって前記凝集物の明視野像及び位相差像を得るステップと、
前記明視野像及び前記位相差像に対して画像処理を行い、前記明視野像及び前記位相差像間の差分画像を得るステップと、
前記差分画像に基づいて、前記凝集物中の前記固形物と前記ゲル状物とを識別するステップと、
を具えることを特徴とする、凝集状態検出方法。
Aggregating a solid in the water to be treated with a chemical to obtain an agglomerate comprising the solid and a gel-like material formed so as to surround the solid;
Obtaining a bright-field image and a phase-contrast image of the aggregate by imaging means;
Performing image processing on the bright field image and the phase difference image to obtain a difference image between the bright field image and the phase difference image;
Identifying the solid and the gel in the aggregate based on the difference image;
A method for detecting an aggregation state, comprising:
前記凝集物中の前記固形物と前記ゲル状物とを識別した後、前記ゲル状物に対する前記固形物の面積比、または前記固形物に対する前記ゲル状物の面積比を算出するステップをさらに具えることを特徴とする、請求項1に記載の凝集状態検出方法。   The method further comprises the step of calculating the area ratio of the solid substance to the gel substance or the area ratio of the gel substance to the solid substance after identifying the solid substance and the gel substance in the aggregate. The aggregation state detection method according to claim 1, wherein: 前記ゲル状物に対する前記固形物の面積比、または前記固形物に対する前記ゲル状物の面積比の閾値に基づいて、前記薬剤の量の過不足を判定するステップをさらに備えることを特徴とする、請求項2に記載の凝集状態検出方法。   The method further comprises determining whether the amount of the drug is excessive or insufficient based on an area ratio of the solid to the gel or a threshold of an area ratio of the gel to the solid. The aggregation state detection method according to claim 2. 被処理水中の固形物を槽中で薬剤を用いて凝集させ、前記固形物及び当該固形物を囲むようにして形成されたゲル状物を含む凝集物を得るステップと、
前記槽中から前記凝集物を取出し、撮像手段によって前記凝集物の明視野像及び位相差像を得るステップと、
前記明視野像及び前記位相差像に対して画像処理を行い、前記明視野像及び前記位相差像間の差分画像を得るステップと、
前記差分画像に基づいて、前記凝集物中の前記固形物と前記ゲル状物とを識別するステップと、
前記凝集物中の前記固形物と前記ゲル状物とを識別した後、前記ゲル状物に対する前記固形物の面積比、または前記固形物に対する前記ゲル状物の面積比を算出するステップと、
前記面積比が、閾値を上回ったときに前記薬剤の量が過剰であると判定し、前記薬剤の供給量を減少若しくは前記薬剤の供給を停止し、前記閾値を下まわったときに前記薬剤の量が不足していると判定し、前記薬剤の供給量を増大若しくは前記薬剤の供給を開始するステップと、
を具えることを特徴とする、凝集状態制御方法。
Aggregating solids in water to be treated with chemicals in a tank to obtain agglomerates including the solids and a gel-like material formed so as to surround the solids;
Taking out the aggregate from the tank and obtaining a bright-field image and a phase-contrast image of the aggregate by imaging means;
Performing image processing on the bright field image and the phase difference image to obtain a difference image between the bright field image and the phase difference image;
Identifying the solid and the gel in the aggregate based on the difference image;
After identifying the solid and the gel in the aggregate, calculating an area ratio of the solid to the gel or an area ratio of the gel to the solid;
When the area ratio exceeds a threshold, it is determined that the amount of the drug is excessive, the supply amount of the drug is decreased or the supply of the drug is stopped, and when the area ratio falls below the threshold, Determining that the amount is insufficient, and increasing the supply amount of the medicine or starting the supply of the medicine; and
A method for controlling the aggregation state, comprising:
被処理水中の固形物を薬剤を用いて凝集させて得られ、前記固形物及び当該固形物を囲むようにして形成されたゲル状物を含む凝集物の明視野像及び位相差像を得るための撮像手段と、
前記明視野像及び前記位相差像に対して画像処理を行い、前記明視野像及び前記位相差像間の差分画像を得、前記差分画像に基づいて、前記凝集物中の前記固形物と前記ゲル状物とを識別するための演算手段と、
を具えることを特徴とする、凝集状態検出装置。
Obtained solids in the water to be treated is coagulated with drug agents, to obtain a bright field image and the phase contrast images of an aggregate comprising the solid and gel-like material formed so as to surround the solid Imaging means;
Perform image processing on the bright field image and the phase difference image, obtain a difference image between the bright field image and the phase difference image, and based on the difference image, the solid matter in the aggregate and the A computing means for identifying the gel-like material;
An agglomeration state detection apparatus comprising:
前記演算手段は、前記凝集物中の前記固形物と前記ゲル状物とを識別した後、前記ゲル状物に対する前記固形物の面積比、または前記固形物に対する前記ゲル状物の面積比を算出するように構成されたことを特徴とする、請求項5に記載の凝集状態検出装置。   The computing means, after identifying the solid and the gel in the aggregate, calculates the area ratio of the solid to the gel or the area ratio of the gel to the solid The aggregating state detection device according to claim 5, wherein the aggregating state detection device is configured to do so. 前記演算手段は、前記面積比が、閾値を上回ったときに前記薬剤の量が過剰であると判定し、前記閾値を下まわったときに前記薬剤の量が不足していると判定するように構成されたことを特徴とする、請求項6に記載の凝集状態検出装置。 The calculation means determines that the amount of the drug is excessive when the area ratio exceeds a threshold value, and determines that the amount of the drug is insufficient when the area ratio falls below the threshold value. The aggregation state detection apparatus according to claim 6, which is configured. 被処理水中の固形物を薬剤を用いて凝集させて得られ、前記固形物及び当該固形物を囲むようにして形成されたゲル状物を含む凝集物の明視野像及び位相差像を得るための撮像手段と、
前記明視野像及び前記位相差像に対して画像処理を行い、前記明視野像及び前記位相差像間の差分画像を得、前記差分画像に基づいて、前記凝集物中の前記固形物と前記ゲル状物とを識別した後、前記ゲル状物に対する前記固形物の面積比、または前記固形物に対する前記ゲル状物の面積比を算出し、前記面積比が、閾値を上回ったときに前記薬剤の量が過剰であると判定し、前記薬剤の供給量を減少若しくは前記薬剤の供給を停止し、前記閾値を下まわったときに前記薬剤の量が不足していると判定し、前記薬剤の供給量を増大若しくは前記薬剤の供給を開始する演算制御手段と、
を具えていることを特徴とする、凝集状態制御装置。
Obtained solids in the water to be treated is coagulated with drug agents, to obtain a bright field image and the phase contrast images of an aggregate comprising the solid and gel-like material formed so as to surround the solid Imaging means;
Perform image processing on the bright field image and the phase difference image, obtain a difference image between the bright field image and the phase difference image, and based on the difference image, the solid matter in the aggregate and the After identifying the gel-like substance, the area ratio of the solid substance to the gel-like substance or the area ratio of the gel-like substance to the solid substance is calculated, and when the area ratio exceeds a threshold, the drug It is determined that the amount of the drug is excessive, the supply amount of the drug is decreased or the supply of the drug is stopped, and when the amount falls below the threshold, the amount of the drug is determined to be insufficient, An arithmetic control means for increasing the supply amount or starting the supply of the medicine;
An agglomerated state control device, comprising:
JP2014127192A 2014-06-20 2014-06-20 Aggregation state detection method, aggregation state control method, aggregation state detection device, and aggregation state control device Active JP6334285B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014127192A JP6334285B2 (en) 2014-06-20 2014-06-20 Aggregation state detection method, aggregation state control method, aggregation state detection device, and aggregation state control device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014127192A JP6334285B2 (en) 2014-06-20 2014-06-20 Aggregation state detection method, aggregation state control method, aggregation state detection device, and aggregation state control device

Publications (2)

Publication Number Publication Date
JP2016006395A JP2016006395A (en) 2016-01-14
JP6334285B2 true JP6334285B2 (en) 2018-05-30

Family

ID=55224907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014127192A Active JP6334285B2 (en) 2014-06-20 2014-06-20 Aggregation state detection method, aggregation state control method, aggregation state detection device, and aggregation state control device

Country Status (1)

Country Link
JP (1) JP6334285B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002079261A (en) * 2000-09-07 2002-03-19 Yoshiro Wakimura Flocculation method
JP5737707B2 (en) * 2008-03-04 2015-06-17 クリスタル バイオサイエンス インク.Crystal Bioscience Inc. Gel-like microdrop composition and method of using the same

Also Published As

Publication number Publication date
JP2016006395A (en) 2016-01-14

Similar Documents

Publication Publication Date Title
JP6730467B2 (en) Coagulation sedimentation control device, coagulation sedimentation device, coagulation sedimentation control method and computer program
JP4793193B2 (en) Aggregation apparatus and aggregation method
JP2016191679A (en) Flocculation state detection method, chemical injection control method and chemical injection control device
JP2006272311A (en) Apparatus and method for coagulation
JP2017026527A (en) Coagulation settling control device, coagulation settling control method, computer program and coagulation settling system
JP5401087B2 (en) Flocculant injection control method
JP2019089022A (en) Flocculant injection controller, flocculant injection control method and flocculant injection control system
JP6633342B2 (en) Coagulant injection support device and control method
JP6139349B2 (en) Water treatment system
JP6437394B2 (en) Water treatment method, water treatment facility, injected flocculant amount evaluation system and residual flocculant amount estimation device
JP6739913B2 (en) Aggregation-precipitation control device, aggregation-precipitation control method and computer program
JP2013120107A (en) Floc strength measuring instrument
JP2017136545A (en) Coagulation control device
JP6139314B2 (en) Aggregation control apparatus and aggregation control method
JP6334285B2 (en) Aggregation state detection method, aggregation state control method, aggregation state detection device, and aggregation state control device
JP7074406B2 (en) Drug addition amount control device and drug addition amount control method
JP6797718B2 (en) Aggregation control device, aggregation control method and aggregation control system
WO2016006419A1 (en) Clumping method and clumping device
JP7003165B2 (en) Coagulation treatment system, coagulation treatment method, computer program and coagulation treatment control device
JP6270655B2 (en) Flock aggregation condition control method, floc aggregation condition control device, water treatment method and water treatment apparatus
JP2004290926A (en) Flocculation precipitation apparatus
JP2011167656A (en) Treatment method of inorganic material-suspended waste water
JP6173808B2 (en) Setting method of coagulant injection rate
JP5210948B2 (en) Chemical injection control method for water purification plant
KR20140059557A (en) Water treating apparatus with means for adjusting injection amount of coagulant and method for adjusting injection amount of coagulant

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170303

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20170908

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20170908

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180109

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180301

TRDD Decision of grant or rejection written
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180301

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180327

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180426

R150 Certificate of patent or registration of utility model

Ref document number: 6334285

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150